Mizoe A, Yamaguchi J, Azuma T, Fujioka H, Furui J, Kanematsu T
Department of Surgery II, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Hepatogastroenterology. 2000 Nov-Dec;47(36):1706-10.
Transcatheter hepatic arterial embolization and lipiodolization have been reported to be effective palliative treatments for patients with unresectable hepatocellular carcinoma. We experienced 2 patients with advanced hepatocellular carcinoma which were initially considered to be unresectable due to the extreme extension of the primary lesions. Therefore, transcatheter hepatic arterial embolization with lipiodolization were selected as the treatments of choice. Thereafter, these tumors markedly decreased in size and, as a result, curative resections could subsequently be performed. The pathological examination of the resected specimens revealed necrosis and hyaline degeneration in the main tumors. Viable tumor cells, however, still remained adjacent to the main tumors. Such evidence indicated the limited efficacy of transcatheter hepatic arterial embolization with lipiodolization and the necessity of performing surgical treatment in combination with transcatheter hepatic arterial embolization with lipiodolization. Based on these findings, transcatheter hepatic arterial embolization with lipiodolization both appear to be a good mode of therapy for advanced hepatocellular carcinoma, and in selected patients, subsequent surgery can also be considered.
经导管肝动脉栓塞术及碘油栓塞术已被报道为无法切除的肝细胞癌患者有效的姑息性治疗方法。我们遇到2例晚期肝细胞癌患者,最初因原发灶广泛扩散而被认为无法切除。因此,选择经导管肝动脉碘油栓塞术作为首选治疗方法。此后,这些肿瘤明显缩小,结果随后可以进行根治性切除。切除标本的病理检查显示主要肿瘤有坏死和透明变性。然而,仍有存活的肿瘤细胞紧邻主要肿瘤。这些证据表明经导管肝动脉碘油栓塞术的疗效有限,以及联合经导管肝动脉碘油栓塞术进行手术治疗的必要性。基于这些发现,经导管肝动脉碘油栓塞术似乎都是晚期肝细胞癌的一种良好治疗方式,对于部分患者,后续手术也可考虑。